NICE expands reach of Erbitux in colorectal cancer
admin 2nd March 2017 Uncategorised 0Cost regulators for the NHS treatments in England and Wales are expanding the scope of Merck’s Erbitux so that the therapy will be routinely available to treat a wider range of patients with metastatic colorectal cancer (mCRC).
Source: News